M. Shahid

Celiac-Related Autoantibodies and IL-17A in Bulgarian Patients with Dermatitis Herpetiformis: A Cross-Sectional Study

T. Velikova, S. Vassileva, E. Ivanova-Todorova, 2019, Medicina.

Updated S2 K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (EADV)

R. Bergman, E. Sprecher, D. Zillikens, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

Nickel and Skin: From Allergy to Autoimmunity.

S. Vassileva, M. Shahid, K. Drenovska, 2019, Endocrine, metabolic & immune disorders drug targets.

Serum autoantibody reactivity in bullous pemphigoid is associated with neuropsychiatric disorders and the use of antidiabetics and antipsychotics: a large, prospective cohort study

I. König, D. Zillikens, M. Worm, 2022, Journal of the European Academy of Dermatology and Venereology : JEADV.

S2k guidelines (consensus statement) for diagnosis and therapy of dermatitis herpetiformis initiated by the European Academy of Dermatology and Venereology (EADV)

F. Valitutti, G. Cianchini, I. Korponay-Szabó, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

Association of specific HLA alleles and haplotypes with pemphigus vulgaris in the Bulgarian population

S. Vassileva, M. Ivanova, E. Naumova, 2022, Frontiers in Immunology.

Case Report: Rowell Syndrome–Like Flare of Cutaneous Lupus Erythematosus Following COVID-19 Infection

S. Vassileva, M. Shahid, K. Drenovska, 2022, Frontiers in Medicine.

Direct patient-to-physician teledermatology: Not a flash in the pan(demic).

V. Vassilev, S. Vassileva, M. Shahid, 2020, Clinics in dermatology.

Case Report: Coexistence of bullous pemphigoid and psoriasis: Therapeutic challenge and IL17A-targeted parallel treatment strategy

S. Vassileva, M. Shahid, K. Drenovska, 2023, Frontiers in Medicine.

Epidermolysis Bullosa Acquisita Mimicking Linear IgA Bullous Disease in a 5-year-old Child.

S. Vassileva, G. Mateev, M. Shahid, 2020, Acta dermatovenerologica Croatica : ADC.